Usefulness of Transcatheter Aortic Valve Implantation for Treatment of Pure Native Aortic Valve Regurgitation

Patients with pure native aortic valve regurgitation (NAVR) and increased surgical risk are often denied surgery. This retrospective study aimed to evaluate the “off-label” use of transcatheter heart valves (THV) for the treatment of NAVR. A total of 254 high surgical risk patients with NAVR (age 74...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of cardiology 2018-09, Vol.122 (6), p.1028-1035
Hauptverfasser:	De Backer, Ole, Pilgrim, Thomas, Simonato, Matheus, Mackensen, G. Burkhard, Fiorina, Claudia, Veulemanns, Verena, Cerillo, Alfredo, Schofer, Joachim, Amabile, Nicolas, Achkouty, Guy, Schäfer, Ulrich, Deutsch, Marcus-André, Sinning, Jan-Malte, Rahman, Mohammed S., Sawaya, Fadi J., Hildick-Smith, David, Hernandez, Jose Maria, Kim, Won-Keun, Lefevre, Thierry, Seiffert, Moritz, Bleiziffer, Sabine, Petronio, Anna Sonia, Van Mieghem, Nicolas, Taramasso, Maurizio, Søndergaard, Lars, Windecker, Stephan, Latib, Azeem, Dvir, Danny
Format:	Artikel
Sprache:	eng
Schlagworte:	Aortic valve Clinical outcomes Consortia Endocarditis Heart valves Implantation Medical personnel Mortality Patients Regurgitation Risk Risk groups Stroke Success Surgery Thorax Transplants & implants
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!